VECCHIO, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 1.186
AS - Asia 742
EU - Europa 549
SA - Sud America 96
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 2.588
Nazione #
US - Stati Uniti d'America 1.136
SG - Singapore 413
IT - Italia 293
CN - Cina 167
DE - Germania 97
BR - Brasile 76
IN - India 67
SE - Svezia 42
VN - Vietnam 41
CA - Canada 40
FI - Finlandia 31
GB - Regno Unito 30
HK - Hong Kong 12
FR - Francia 11
NL - Olanda 10
KR - Corea 9
ES - Italia 8
JP - Giappone 8
ZA - Sudafrica 8
MX - Messico 7
AR - Argentina 6
BD - Bangladesh 5
CZ - Repubblica Ceca 5
RU - Federazione Russa 5
UA - Ucraina 5
CL - Cile 3
ID - Indonesia 3
PL - Polonia 3
RO - Romania 3
SA - Arabia Saudita 3
AT - Austria 2
CO - Colombia 2
EC - Ecuador 2
EU - Europa 2
IL - Israele 2
IR - Iran 2
KZ - Kazakistan 2
PE - Perù 2
PY - Paraguay 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AQ - Antartide 1
BB - Barbados 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GR - Grecia 1
KE - Kenya 1
LT - Lituania 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
SR - Suriname 1
TR - Turchia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.588
Città #
Dallas 284
Singapore 181
Chandler 140
Munich 78
Catanzaro 60
Santa Clara 57
Bengaluru 52
Hefei 52
Milan 50
Ashburn 47
Lawrence 44
Princeton 44
Turku 29
Seattle 28
Boardman 27
Beijing 26
Ottawa 26
Wilmington 23
London 20
Ho Chi Minh City 17
Des Moines 14
Chicago 12
Hong Kong 12
Los Angeles 12
Cosenza 11
Napoli 11
Taranto 11
São Paulo 10
Hanoi 8
Foggia 7
Augusta 6
Bari 6
Brooklyn 6
Norwalk 6
San Francisco 6
Naples 5
Olomouc 5
Redmond 5
Boston 4
Caserta 4
Hanover 4
Johannesburg 4
Latina 4
Marano 4
Montreal 4
New York 4
Paris 4
Phoenix 4
Pune 4
Rio de Janeiro 4
Rome 4
Shanghai 4
The Dalles 4
Tokyo 4
West Jordan 4
Xi'an 4
Atlanta 3
Council Bluffs 3
Ferrara 3
Huế 3
Mumbai 3
Redwood City 3
Reggio Calabria 3
Stockholm 3
Toronto 3
Warsaw 3
Adrano 2
Amsterdam 2
Assago 2
Aversa 2
Bagnara Calabra 2
Belgrade 2
Birmingham 2
Bogotá 2
Campinas 2
Cape Town 2
Charlotte 2
Clifton 2
Columbus 2
Dalian 2
Dalmine 2
Edmonton 2
Gallipoli 2
Genoa 2
Guangzhou 2
Hangzhou 2
Helsinki 2
Honolulu 2
Itabaiana 2
Jiaxing 2
Las Vegas 2
Mapo-gu 2
Milazzo 2
Montalto Uffugo 2
Mugnano di Napoli 2
Oklahoma City 2
Omaha 2
Philadelphia 2
Riyadh 2
Romainville 2
Totale 1.608
Nome #
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 129
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 92
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α 77
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 76
A novel phage display based platform for exosome diversity characterization 73
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 68
Evidence for a novel Cullin-3/IBtk human ubiquitin ligase complex 67
Crucial role for IBtk in the survival and maintenance of mature B cells 67
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 67
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 66
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 66
Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet 65
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder 64
Human immunodeficiency virus-1 Tat activates NF-kappaB via physical interaction with IkappaB-alpha and p65 62
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 61
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 60
The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection 57
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 56
Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 54
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 54
FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma 53
Exploring the effects of paclitaxel-loaded zein nanoparticles on human ovarian carcinoma cells 52
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 51
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 50
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 49
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 49
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 49
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 47
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 47
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 47
The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis 47
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 47
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 46
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 43
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 42
Id-peptides as biomarkers of B-cell Chronic Lymphocytic Leukemia 41
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 40
Id-peptides as new tools for diagnosis and treatment of B-cell Chronic Lymphocytic Leukemia (B-CLL) 40
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 40
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 39
Insights into Thymus Development and Viral Thymic Infections 38
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2 37
Id peptide-based methodology to explore the antigenic diversity of B-cell Chronic Lymphocytic Leukemia (B-CLL) 37
Iron affects the sphere-forming ability of ovarian cancer cells in non-adherent culture conditions 34
The Double-Edged Sword of Oleuropein in Ovarian Cancer Cells: From Antioxidant Functions to Cytotoxic Effects 33
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 29
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 27
Influence of fibroblasts on mammary gland development, breast cancer microenvironment remodeling, and cancer cell dissemination 25
Mass Spectrometry-Based Identification of a Tumor Sialoglycoprotein Antigen involved in Cancer Progression 24
Revisiting Bacterial Ubiquitin Ligase Effectors: Weapons for Host Exploitation 21
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 20
The Inhibitor Of Bruton’ Tyrosine Kinase-G Regulates The Btk Signaling In B Cells 20
Overcoming BET‐inhibitor JQ1 resistance in aggressive non‐small cell lung cancer by inducing ferroptosis via inhibition of the BRD2–FTH1 axis 18
null 6
Totale 2.669
Categoria #
all - tutte 24.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.776


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202193 0 0 0 0 8 8 10 1 30 28 0 8
2021/2022175 6 0 5 39 7 8 9 46 11 19 23 2
2022/2023420 90 21 31 16 48 26 7 40 77 26 29 9
2023/2024227 41 22 16 9 10 53 21 11 3 7 7 27
2024/2025758 94 29 28 26 75 80 20 22 106 24 115 139
2025/2026876 113 175 308 141 139 0 0 0 0 0 0 0
Totale 2.669